Advice Pool - Insurance

While there are genuine debates about whether privatized health insurance or nationalized health insurance policies make more sense, there can be little doubt that guarantee issue policies repres

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ent the most immoral type of hybrid between the two. The argument that everyone should be covered by health insurance is an argument for a nationalized health care policy. By contrast, believer

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

in privatized health insurance argue that a private system yields more efficient pricing and cost controls in the health care field. But with guarantee issue health insurance policies, an immor

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

al situation is created that undermines the benefits of a privatized system by poorly and immorally implementing some of the edicts of a nationalized system.

Canada has a nationalized health car

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

policy that many in the U.S. wish to emulate. While the idea of promising health care benefits to all citizens is appealing, there are downsides. For example, many in Canada are forced into lo

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ng waiting lines to receive health care treatment. In fact, the Canadian courts just ruled that many laws which barred citizens from seeking alternative health insurance options were unconstitut

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

onal. If the health care system in Canada were capable of serving all citizens in a timely manner, there would be no need to seek alternate routes. The Canadian courts were correct to view laws

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

limiting how people can spend their own money for their own health benefits as inconsistent with their fundamental freedoms. But barring those attempts by legislators to enforce a monopoly on n

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

tionalized health insurance, the premise of taxpayers supporting a nationalized health care system makes sense from an ethical point of view. In such a system all taxpayers are subject to the sa

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

me benefits and burdens with respect to their existing tax structures.

Similarly, a privatized health insurance system like that in place in the United States makes sense from an ethical standpo

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

nt. While it can lead to tragedies where uninsured people contract illnesses and cannot pay for medical treatment, it treats people in a fundamentally fair manner. Everyone is free to make thei

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

own decisions, and pay or suffer the potential consequences. Those who wish to spend money to guarantee funds are available in case of medical emergencies are free to do so, and at a price that

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

falls within their statistical risks.

But guarantee issue laws for health insurance companies are fundamentally unfair. They punish those who are willing to pay for insurance by saddling them

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ith costs far beyond what they should owe statistically, or what they should owe in a nationalized system. Health insurance rates in guarantee issue states like New York and New Jersey are aroun

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

d 3 to 4 times what they are in other states. Is it fair for a consumer in New Jersey to pay three times as much for the same health insurance as they would in another state? Of course it isn’t

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

These consumers have been unfairly placed into a statistical pool that isn’t representative of their health care needs, and forced to pay far more for health insurance than their situation dict

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ates. And they are forced into this situation precisely because lawmakers have chosen a terrible hybrid model that removes any pretense of fairness in pricing that exist in the more natural nati

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

nalized and privatized models.

As more and more people in the guarantee issue states become unable to afford health insurance, those states will be forced to answer for the fact that their polic

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ies have made them leaders in the numbers of uninsured. A new law called the Health Care Choice Act is being proposed to allow residents of one state to purchase health insurance from another.

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

hile legislators in guarantee issue states will oppose such laws, they’ll have a hard time pretending they’re doing so on behalf of their constituents who are actually paying for health insurance

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/124761/advicepool-The-Immorality-of-Guarantee-Issue-Health-Insurance.html">The Immorality of Guarantee Issue Health Insurance</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/124761/advicepool-The-Immorality-of-Guarantee-Issue-Health-Insurance.html]The Immorality of Guarantee Issue Health Insurance[/url]

Now you have quit your job you think are the hot shot you always were but will your clients still see it that way? Now you are working from home should your charge out rate still be $800 an hour as it once was or has something changed?

Finance. We hear that word thrown around quite a bit, but you may be surprised, however, just how many people have no real idea what is meant by finance. In fact, it’s safe to say that much of America has a better fix on the goings on inside the Big Brother house than they do on what happens at the Federal Reserve! This is sad, but true.

Tags

Links

Advice Pool - The Immorality of Guarantee Issue Health Insurance

Related Articles: